Therapy Areas: Vaccines
Novavax makes one million doses of protein-based COVID-19 vaccine available in UK
27 September 2022 - Biotechnology company Novavax Inc (Nasdaq:NVAX) announced on Tuesday that an initial one million doses of its COVID-19 vaccine Nuvaxovid are now available for use in the UK.Nuvaxov...
First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
26 September 2022 - - US-based nonprofit scientific research organization IAVI said volunteers at the PREVAIL clinical trial site at Redemption Hospital in Monrovia, Liberia, have been vaccinated with...
Pfizer and BioNTech seek FDA approval of new Omicron-tailored COVID-19 booster for children
26 September 2022 - US biopharmaceutical company Pfizer Inc (NYSE: PFE) and its partner, German biotechnology company BioNTech SE (Nasdaq: BNTX), announced on Monday that they have applied to the US F...
RVAC Medicines' phase one, first-in-human study assessing mRNA-based COVID-19 vaccine candidate RVM-V001 doses first participant
22 September 2022 - RVAC Medicines Pte. Ltd., a Singapore-based messenger RNA (mRNA) technology platform company incubated by CBC Group, announced on Wednesday that it has dosed a participant in a pha...
First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
21 September 2022 - - US-based nonprofit scientific research organization IAVI said volunteers at the PREVAIL clinical trial site at Redemption Hospital in Monrovia, Liberia, have been vaccinated with...
First Volunteers Vaccinatated at Liberia Site in Phase I Clinical Trial of Lassa Fever Vaccine Candidate
20 September 2022 - - US-based nonprofit scientific research organization IAVI said volunteers at the PREVAIL clinical trial site at Redemption Hospital in Monrovia, Liberia, have been vaccinated with...